Lynx1 Capital Management LP

CIK

1910456

City

DORADO

State / Country

PR

Stock

GHRS — GH Research PLC

Top Portfolio Positions

22 positions · $783,926,820 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
GHRS	GH Research PLC Healthcare	21,526,576	$302,663,658	38.61%
STOK	Stoke Therapeutics, Inc. Healthcare	4,763,673	$155,105,192	19.79%
CGEM	Cullinan Therapeutics, Inc. Healthcare	8,963,500	$127,371,335	16.25%
AGIO	Agios Pharmaceuticals, Inc. Healthcare	2,611,568	$88,349,345	11.27%
DNLI	Denali Therapeutics Inc. Healthcare	1,880,303	$36,101,817	4.61%
CCCC	C4 Therapeutics, Inc. Healthcare	6,998,902	$18,407,112	2.35%
KRRO	Korro Bio, Inc. Healthcare	1,538,296	$17,413,510	2.22%
TCRX	TScan Therapeutics, Inc. Healthcare	8,019,148	$8,099,339	1.03%
XNCR	Xencor Inc Healthcare	536,398	$6,468,959	0.83%
DTIL	Precision Biosciences Inc Healthcare	985,113	$5,418,121	0.69%

Portfolio Trend

18 quarters · across all stocks

Holdings in GHRS

Compact Export CSV

Shares Held

Position Value (USD)

12 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$151,331,829	10,763,288	0.0%	Shares	Other	2026-05-04
2026-03-31	$151,331,829	10,763,288	+3.4%	Shares	Sole	2026-05-18
2025-12-31	$132,163,502	10,406,575	+21.0%	Shares	Other	2026-02-17
2025-09-30	$122,997,002	8,601,189	+27.5%	Shares	Other	2025-11-13
2025-06-30	$82,245,332	6,746,951	+4.7%	Shares	Other	2025-08-14
2025-03-31	$71,076,658	6,443,940	+1.4%	Shares	Other	2025-05-15
2025-02-06	$85,829,962	6,353,069	+30.7%	Shares	Sole	2025-02-10
2024-12-31	$34,012,958	4,858,994	+15.8%	Shares	Other	2025-02-14
2024-09-30	$28,070,530	4,195,894	+128.2%	Shares	Other	2024-11-14
2023-12-31	$10,663,978	1,838,617	+66.7%	Shares	Other	2024-02-14
2023-09-30	$11,086,938	1,103,178	+13.8%	Shares	Other	2023-11-14
2023-06-30	$11,501,622	969,374	—	Shares	Other	2023-08-14
No 13F history on record for this holder in this stock.